-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Zenas BioPharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2023 to Q2 2025.
- Zenas BioPharma, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $20K.
- Zenas BioPharma, Inc. annual Income Tax Expense (Benefit) for 2024 was $429K, a 42.5% increase from 2023.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)